HyperRAB® S/D [Rabies Immune Globulin (Human)]
postexposure prophylaxis for rabies
HyperRAB® S/D Postexposure Prophylaxis for Rabies
Up to 39,000 persons come in contact with potentially rabid animals and receive rabies postexposure prophylaxis each year.1,2
According to the Centers for Disease Control and Prevention (CDC), rabies is almost always fatal, but is almost 100% preventable with the comprehensive treatment that can only be provided with a rabies immune globulin, such as HyperRAB S/D in conjunction with a vaccine, such as RabAvert® (rabies vaccine).3,4
For more information, recommendations, and guidelines, visit the CDC—Advisory Committee on Immunization Practices (ACIP).
Vaccines can take weeks to build efficacy. HyperRAB S/D provides immediate protection. This allows the vaccine the time needed to establish active immunity, giving your patients the critical protection they need now.5
HyperRAB S/D contains high titers of rabies antibodies for postexposure prophylaxis, providing rapid immune protection. When used in combination with a vaccine, such as RabAvert, along with the appropriate wound cleansing, a rabies immune globulin such as HyperRAB S/D is recommended by the CDC and WHO.1,6,7*